Related Experiment Video
Updated: Apr 14, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.7K
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study.
Elisabetta Lolli1, Rosita Saraceno2, Emma Calabrese1
1GI Unit, Department of Systems Medicine, University Tor Vergata of Rome, Italy.
Journal of Crohn'S & Colitis
|April 25, 2015
Summary
Psoriasis severity and phenotypes differ between inflammatory bowel disease (IBD) patients and non-IBD controls. Mild psoriasis is more common in IBD, while moderate to severe forms are more frequent in non-IBD individuals.
Area of Science:
- Dermatology
- Gastroenterology
- Immunology
Background:
- The relationship between inflammatory bowel disease (IBD) and specific psoriasis phenotypes remains unclear.
- This study investigates psoriasis characteristics in IBD patients compared to matched non-IBD controls.
Purpose of the Study:
- To assess and compare the severity and phenotypes of psoriasis in patients with IBD versus those without IBD.
Main Methods:
- A prospective case-control study was conducted from 2011 to 2013.
- Dermatological assessments evaluated psoriasis presence, characteristics, and severity in IBD patients.
- IBD patients with psoriasis were matched with non-IBD controls based on gender, ethnicity, and age.
Main Results:
- Of 251 IBD patients, 62 (25%) had psoriasis. Mild psoriasis was significantly more frequent in IBD patients (87%) compared to non-IBD controls (53%).
- Moderate and severe psoriasis were more prevalent in non-IBD controls (37% and 10%) than in IBD patients (13% and 0%).
- Plaque-type psoriasis was common in both groups, but plaque-type, nail psoriasis, and psoriatic arthritis were less frequent in IBD patients.
Conclusions:
- Psoriasis severity and phenotypes exhibit distinct patterns in IBD patients compared to non-IBD individuals.
- These findings suggest a potential link between IBD and specific psoriasis presentations.
More Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
01:17Chronic Bowel Disorders: Introduction
950
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
950
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
986
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
986
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
716
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
716